← Leaderboards
Gisela Velez
Schepens Eye Research Institute
$1,185,217
Attributed
$1,185,217
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $256.8K · FY2007–11$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$1,185,217 · 1
By mechanism
K08$1,185,217 · 1
Top collaborators
No co-investigators on record.
Most similar at Schepens Eye Research Institute
Same institution · by research overlap
- Andrius Kazlauskas$15,558,315
- Ann E Elsner$9,473,451
- Hetian Lei$1,001,032
Others in their field
Top investigators on “Drug Kinetics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$241,865,009
- Sharon A Nachman · Johns Hopkins University$194,646,762
- Carol Nesel · Westat$147,274,423
- Barbara Driver · Westat, Inc.$103,746,400
- Ronald T Mitsuyasu · University Of California Los Angeles$99,239,507
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,714,869
Research focus
Drug KineticsAbl1 GeneAdverse EffectsAutocrineBaseBcr-Abl Tyrosine KinaseC-Abl Proto-OncogenesAttenuatedCataractCellsCharacteristicsCicatrixClinical TrialsComplementComplexComplicationCareerDensityDisease ModelDominant-Negative MutationDosageDoseDrug ClearanceEpiretinal Membrane
Grant awards (7)
Pharmacologic inhibitors of PDGFR for the treatment of PVR$204,376
K08 · FY2011 · EY · contact PI
Pharmacologic inhibitors of PDGFR for the treatment of PVR$27,729
K08 · FY2011 · EY · contact PI
Pharmacologic inhibitors of PDGFR for the treatment of PVR$232,105
K08 · FY2010 · EY · contact PI
Pharmacologic inhibitors of PDGFR for the treatment of PVR$232,105
K08 · FY2009 · EY · contact PI
Pharmacologic inhibitors of PDGFR for the treatment of PVR$232,105
K08 · FY2008 · EY · contact PI
Pharmacologic inhibitors of PDGFR for the treatment of PVR$24,692
K08 · FY2008 · EY · contact PI
Pharmacologic inhibitors of PDGFR for the treatment of PVR$232,105
K08 · FY2007 · EY · contact PI